Alivexis, Inc

Rowanalytics Inc, based in Cambridge, MA, is a pioneering company focused on improving health outcomes by predicting and preventing complex chronic diseases. Utilizing advanced mechanostics and world-class analytics, they develop personalized diagnostic tools and treatment options to address unmet medical needs, aiming to enhance healthcare diagnostics and drug development. With a mission to reduce the global burden of chronic diseases, Rowanalytics employs hypothesis-free combinatorial analytics to uncover disease mechanisms and stratify patients effectively. Their unique approach integrates multimodal patient data to generate actionable insights, maximizing the probability of successful drug development and providing precision medicine solutions for billions of people. Generated from the website

Q32 Bio Inc is a clinical stage biotechnology company based in Cambridge, MA. They are focused on developing biologic therapeutics to restore immune homeostasis. Their pipeline includes innovative treatments for complement disorders, atopic dermatitis, and alopecia areata. Q32 Bio has recently announced significant milestones, including the merger with Homology Medicines and the re-acquisition of worldwide development and commercial rights for their clinical development candidates. With a team of experienced professionals and a commitment to advancing scientific research, Q32 Bio is dedicated to improving the lives of patients with autoimmune diseases.Generated from the website

BioDataSci Inc, located in Cambridge, MA, specializes in developing custom digital solutions tailored for cross-disciplinary life-science research and cloud-connected products. The company collaborates with startups to define their digital product requirements and design robust hybrid-cloud Platform as a Service (PaaS) architectures. With expertise in high-performance data management, AI-enabled systems, and complex data analytics, BioDataSci offers a comprehensive suite of services, including strategy leadership, virtual team building, and modular architecture design. Their capabilities encompass a wide range of technologies from microservices to data science, positioning them as a key partner in the biotech industry. Generated from the website